Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Breast Cancer |
Free Subscription
1 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
Editorial Comment: Utilization of Radiomics to Identify HER2-Low Breast Cancer.
AJR Am J Roentgenol. 2024 Feb 14. doi: 10.2214/AJR.24.30953.
PubMed
ASO Visual Abstract: Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0
Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?
Ann Surg Oncol. 2024 Feb 15. doi: 10.1245/s10434-024-15037.
PubMed
At the Speed of SOUND: The Pace of Change for Axillary Management in Breast
Cancer.
Ann Surg Oncol. 2024 Feb 12. doi: 10.1245/s10434-024-15010.
PubMed
A Prospective Study of Sentinel Node Biopsy Omission in Women Age >/= 65 Years with
ER+ Breast Cancer.
Ann Surg Oncol. 2024 Feb 12. doi: 10.1245/s10434-024-15000.
PubMed
Abstract available
ASO Author Reflections: Neoadjuvant Systemic Therapy and Nodal Management in
cT1-2 N0 Triple-Negative Breast Cancer.
Ann Surg Oncol. 2024 Feb 10. doi: 10.1245/s10434-024-15020.
PubMed
Monitoring trends in the absolute lymphocyte count and the
neutrophil-to-lymphocyte ratio in patients with breast cancer receiving eribulin.
BMC Cancer. 2024;24:195.
PubMed
Abstract available
Dual effect of vitamin D(3) on breast cancer-associated fibroblasts.
BMC Cancer. 2024;24:209.
PubMed
Abstract available
Healthy lifestyles, systemic inflammation and breast cancer risk: a mediation
analysis.
BMC Cancer. 2024;24:208.
PubMed
Abstract available
Correction: The value of oral selective estrogen receptor degraders in patients
with HR-positive, HER2-negative advanced breast cancer after progression on >/= 1
line of endocrine therapy: systematic review and meta-analysis.
BMC Cancer. 2024;24:205.
PubMed
Cyclin-dependent kinase 7 (CDK7) inhibitors as a novel therapeutic strategy for
different molecular types of breast cancer.
Br J Cancer. 2024 Feb 14. doi: 10.1038/s41416-024-02589.
PubMed
Abstract available
Organoid forming potential as complementary parameter for accurate evaluation of
breast cancer neoadjuvant therapeutic efficacy.
Br J Cancer. 2024 Feb 10. doi: 10.1038/s41416-024-02595.
PubMed
Abstract available
A novel approach correlating pathologic complete response with digital pathology
and radiomics in triple-negative breast cancer.
Breast Cancer. 2024 Feb 13. doi: 10.1007/s12282-024-01544.
PubMed
Abstract available
Preliminary report on ultrashort perioperative partial-breast irradiation with
multicatheter interstitial brachytherapy for early-stage breast cancer.
Breast Cancer. 2024 Feb 15. doi: 10.1007/s12282-024-01546.
PubMed
Abstract available
MRI-based tumor shrinkage patterns after early neoadjuvant therapy in breast
cancer: correlation with molecular subtypes and pathological response after
therapy.
Breast Cancer Res. 2024;26:26.
PubMed
Abstract available
Contrast-enhanced ultrasound to predict malignant upgrading of atypical ductal
hyperplasia.
Breast Cancer Res. 2024;26:27.
PubMed
Abstract available
The impact of germline BRCA pathogenic variants in locally advanced, triple
negative breast cancer treated with platinum-based neoadjuvant chemotherapy.
Breast Cancer Res Treat. 2024 Feb 12. doi: 10.1007/s10549-024-07247.
PubMed
Abstract available
Socio-cultural and financial issues against breast cancer screening behaviour
among eligible Indian women: evidence for action.
Breast Cancer Res Treat. 2024 Feb 12. doi: 10.1007/s10549-024-07244.
PubMed
Abstract available
Searching for the "Holy Grail" of breast cancer recurrence risk: a narrative
review of the hunt for a better biomarker and the promise of circulating tumor
DNA (ctDNA).
Breast Cancer Res Treat. 2024 Feb 15. doi: 10.1007/s10549-024-07253.
PubMed
Abstract available
Discovery of a proliferation essential gene signature and actin-like 6A as
potential biomarkers for predicting prognosis and neoadjuvant chemotherapy
response in triple-positive breast cancer.
Cancer. 2024 Feb 15. doi: 10.1002/cncr.35228.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
Differences in Smoking Behavior by Nativity, Race/Ethnicity, and Education Among
Women Diagnosed with Breast Cancer.
Cancer Epidemiol Biomarkers Prev. 2024.
PubMed
Abstract available
Prognostic Value of Pre-treatment Plasma C-Reactive Protein in Patients with
Early-Stage Breast Cancer.
Cancer Epidemiol Biomarkers Prev. 2024.
PubMed
Abstract available
Acidosis activates breast cancer ferroptosis through ZFAND5/SLC3A2 signaling axis
and elicits M1 macrophage polarization.
Cancer Lett. 2024 Feb 13:216732. doi: 10.1016/j.canlet.2024.216732.
PubMed
Abstract available
Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming
that Drives Immune Evasion.
Cancer Res. 2024 Feb 9. doi: 10.1158/0008-5472.CAN-23-2390.
PubMed
Abstract available
Interference of the Circular RNA Sperm Antigen With Calponin Homology and
Coiled-Coil Domains 1 Suppresses Growth and Promotes Apoptosis of Breast Cancer
Cells Partially Through Targeting miR-1236-3p/Chromobox 8 Pathway.
Clin Breast Cancer. 2023 Dec 2:S1526-8209(23)00304.
PubMed
Abstract available
Antibody-Drug Conjugates in Triple Negative Breast Cancer.
Clin Breast Cancer. 2024 Jan 20:S1526-8209(24)00008.
PubMed
Abstract available
Elucidating Axillary Soft Tissue Involvement in Breast Cancer: Unveiling
Metastatic Mechanisms and Therapeutic Perspectives.
Clin Breast Cancer. 2024 Jan 29:S1526-8209(24)00024.
PubMed
Abstract available
Validation of the prognostic performance of Breast Cancer Index (BCI) in hormone
receptor-positive (HR+) postmenopausal breast cancer patients in the TEAM trial.
Clin Cancer Res. 2024 Feb 12. doi: 10.1158/1078-0432.CCR-23-2436.
PubMed
Abstract available
A novel prognostic model of breast cancer based on cuproptosis-related lncRNAs.
Discov Oncol. 2024;15:35.
PubMed
Abstract available
Take a break: should breaks be enforced during digital breast tomosynthesis
reading sessions?
Eur Radiol. 2024;34:1388-1398.
PubMed
Abstract available
Multi-modality radiomics model predicts axillary lymph node metastasis of breast
cancer using MRI and mammography.
Eur Radiol. 2024 Feb 10. doi: 10.1007/s00330-024-10638.
PubMed
Abstract available
Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing
statuses in breast cancer using multiparametric MRI-based radiomics.
Eur Radiol. 2024 Feb 16. doi: 10.1007/s00330-024-10641.
PubMed
Abstract available
RBM10 regulates the tumorigenic potential of human cancer cells by modulating
PPM1B and YBX1 activities.
Exp Cell Res. 2024;435:113932.
PubMed
Abstract available
Hic-5 regulates extracellular matrix-associated gene expression and cytokine
secretion in cancer associated fibroblasts.
Exp Cell Res. 2024;435:113930.
PubMed
Abstract available
A Prospective Study Demonstrating Early Prediction of Skin Toxicity From
Radiation Therapy Using Radiomic Features From Optical and Infrared Images.
Int J Radiat Oncol Biol Phys. 2024;118:839-852.
PubMed
Abstract available
Psychological Outcomes in Adolescent and Young Adult Cancer Survivors.
J Clin Oncol. 2024;42:707-716.
PubMed
Abstract available
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR
06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).
J Clin Oncol. 2024 Feb 9:JCO2301428. doi: 10.1200/JCO.23.01428.
PubMed
Abstract available
Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult
Hodgkin Lymphoma.
J Clin Oncol. 2024 Feb 15:JCO2301386. doi: 10.1200/JCO.23.01386.
PubMed
Abstract available
Association Between Neighborhood Opportunity, Allostatic Load, and All-Cause
Mortality in Patients With Breast Cancer.
J Clin Oncol. 2024 Feb 16:JCO2300907. doi: 10.1200/JCO.23.00907.
PubMed
Abstract available
Supplemental magnetic resonance imaging plus mammography compared with magnetic
resonance imaging or mammography by extent of breast density.
J Natl Cancer Inst. 2024;116:249-257.
PubMed
Abstract available
Activity and safety of enobosarm, a novel, oral, selective androgen receptor
modulator, in androgen receptor-positive, oestrogen receptor-positive, and
HER2-negative advanced breast cancer (Study G200802): a randomised, open-label,
multicentre, multin
Lancet Oncol. 2024 Feb 8:S1470-2045(24)00004.
PubMed
Abstract available
Androgen receptor agonism in advanced oestrogen receptor-positive breast cancer.
Lancet Oncol. 2024 Feb 8:S1470-2045(24)00080.
PubMed
Forget lung, breast or prostate cancer: why tumour naming needs to change.
Nature. 2024;626:26-29.
PubMed
Correction: Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function
to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.
Oncogene. 2024 Feb 14. doi: 10.1038/s41388-024-02961.
PubMed
HER2-low breast cancer and response to neoadjuvant chemotherapy: a
population-based cohort study.
Pathology. 2024 Jan 18:S0031-3025(24)00007-2. doi: 10.1016/j.pathol.2023.
PubMed
Abstract available
Food additive emulsifiers and cancer risk: Results from the French prospective
NutriNet-Sante cohort.
PLoS Med. 2024;21:e1004338.
PubMed
Abstract available
Discovery and characterization of anti-cancer peptides from a random peptide
library.
PLoS One. 2024;19:e0293072.
PubMed
Abstract available
Therapeutic interventions on human breast cancer xenografts promote systemic
dissemination of oncogenes.
PLoS One. 2024;19:e0298042.
PubMed
Abstract available
Early life body size and puberty markers as predictors of breast cancer risk
later in life: A neural network analysis.
PLoS One. 2024;19:e0296835.
PubMed
Abstract available
Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2-
breast tumor cells.
Proc Natl Acad Sci U S A. 2024;121:e2309261121.
PubMed
Abstract available
Thank you for your interest in scientific medicine.